About the AACE Experts

Lawrence Blonde, M.D., FACP, FACE

Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes & Metabolism
Associate Internal Medicine Residency Program Director, Ochsner Medical Center

Lawrence Blonde, M.D., FACP, FACE, is director of the Ochsner Diabetes Clinical Research Unit in the Department of Endocrinology, Diabetes and Metabolism, and an Associate Internal Medicine Residency Program Director at the Ochsner Medical Center in New Orleans, Louisiana.

Dr. Blonde’s clinical and research activities have focused on patients with diabetes mellitus and investigations of new therapies and health care delivery systems for them. He has also published and presented information about the use of computers to enhance medical education and patient care.

Dr. Blonde is a member of the executive committee and past chair of the steering committee of the National Diabetes Education Program, a partnership of the National Institutes of Health, the Centers for Disease Control and Prevention, and more than 200 public and private organizations working to "change the way diabetes is treated."

Dr. Blonde has been a member of the board of directors of the American Association of Clinical Endocrinologists (AACE) and the board of trustees of the American College of Endocrinology (ACE). He is presently a member of the board of directors of the Council for the Advancement of Diabetes Research and Education (CADRE) and has been a member of the National Quality Forum Adult Diabetes Care Consensus Maintenance Committee. Dr. Blonde has been chair of the American Diabetes Association (ADA) Doing Better Committee, a former member of the ADA board of directors, and former chair of the ADA Professional Practice Committee, which develops practice guidelines for the care of people with diabetes.

Dr. Blonde has served on the Microsoft Health Care Users Group Board of Directors, and as a member of the Residency Review Committee for Internal Medicine and the Transitional Review Committee of the Accreditation Council for Graduate Medical Education. He has also been a member of the Council of the Association of Program Directors in Internal Medicine, the Council of the Association of Subspecialty Professors, and the ACP Medical Informatics Subcommittee, for which he served as chair.

 

George Grunberger, M.D., FACP, FACE

Founder & Chairman, Grunberger Diabetes Institute (GDI)
Clinical Professor of Internal Medicine and Molecular Medicine & Genetics, Wayne State University School of Medicine
 Staff Physician, Royal Oak Beaumont Hospital

George Grunberger, M.D., FACP, FACE, received his medical degree from New York University School of Medicine, had internal medicine training at Case Western Reserve University in Cleveland, Ohio and Endocrinology/Metabolism training in the Diabetes Branch at the National Institutes of Health in Bethesda, Maryland. He received his bachelor degree (in biochemistry) at Columbia College of Columbia University, in New York City.

Dr. Grunberger is currently Chairman of the Michigan Chapter of the American Association of Clinical Endocrinologists (AACE) and has served on the National Board of Directors of AACE since 2006. He is a Fellow of the American College of Physicians, and the American College of Endocrinology, and has been an active member of many professional organizations and societies, including the American Diabetes Association, American Association of Clinical Endocrinologists, The Endocrine Society and European Association for the Study of Diabetes.

Early in his career, Dr. Grunberger saw the need for a comprehensive diabetes treatment facility where people with diabetes could receive specialized care and address the many facets of their disease. Before establishing GDI in 2002, Dr. Grunberger was director of the diabetes program at the Detroit Medical Center for 16 years as well as the co-founder and Medical Director of Wayne State University’s Morris J. Hood Comprehensive Diabetes Center.

Dr. Grunberger held tenured full professor appointments at the University in the Department of Internal Medicine and in the Center for Molecular Medicine and Genetics since 1986. Between 1997 and 2001,  he was the Henry L. Brasza Director of the Center for Molecular Medicine and Genetics.

In 1995-1996, Dr. Grunberger served as Interim Chairman of the Department of Internal Medicine and Physician-in-Chief of the Detroit Medical Center. Dr. Grunberger was recruited to Detroit from the Diabetes Branch of the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health, where he worked as a basic and clinical researcher for six years.

Dr. Grunberger’s clinical and basic research endeavors have been well recognized and his interests have spanned the spectrum of subjects related to diabetes and its complications, from very basic studies on molecular underpinning of insulin action and insulin resistance to clinical research studies on many aspects of diabetes and its complications. Dr. Grunberger has published over 100 original peer-reviewed manuscripts, in addition to review articles, abstracts and book chapters. He serves as a co-editor of the international diabetes journal, Diabetes/Metabolism Research & Reviews, and is an active reviewer of manuscripts and grant applications for many professional organizations. In 2002, Dr. Grunberger edited a book on the latest advances in insulin signal transduction.

Dr. Grunberger has been elected by his peers for inclusion in the Best Doctors in America® every year between 2001 and 2012.

 

Yehuda Handelsman, M.D., FACP, FACE, FNLA

Medical Director & Principal Investigator, Metabolic Institute of America
Senior Scientific Consultant, Metabolic Endocrine Education Foundation
Founder & Chairman, International Committee for Insulin Resistance
Chair and Program Director, Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
President, American Association of Clinical Endocrinologists (AACE)
Board Member, Pacific Lipid Association

Yehuda Handelsman, M.D., FACP, FACE, FNLA, is an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilizes a unique and multiple intervention approach to preventing and managing cardiovascular disease in the high risk patient. He has been listed repeatedly in “Southern California Super Doctors.”

Dr. Handelsman is a member of the American College of Endocrinology, American Diabetes Association, National Lipid Association, American Thyroid Association, Academy of Clinical Thyroidologists, American College of Physicians, National Osteoporosis Foundation, Los Angeles, California, and the American Medical Association.

Dr. Handelsman is a past chair of the AACE Diabetes Council, which leads the way in the comprehensive approach to the treatment of diabetes, controlling dyslipidemia, hypertension and hyperglycemia for the prevention and management of complications and cardiovascular disease. He is associate editor for Journal of Diabetes and a frequent guest editor for publications such as Journal of Clinical Hypertension (JCH), Metabolic Syndrome and Related Disorders, and Postgraduate Medicine. As a clinician, researcher and educator, he has published extensively and is a frequent lecturer, both national and international, on diabetes and its comprehensive treatment, hypertension, lipids disorders, insulin, incretins, gut hormones, obesity, insulin resistance, metabolic syndromes, pre-diabetes and prevention of cardiovascular disease. He has been chair, member and co-author of national guidelines and position statements on diabetes, pre-diabetes, lipids & hypertension, and co-chaired consensuses on insulin resistance, polycystic ovarian syndrome and pre-diabetes.

Dr. Handelsman graduated summa cum laude at the University of the Pacific, in Stockton, California.  A fellow of the American College of Endocrinology, the American College of Physicians and the National Lipid Association, he earned his medical degree from the Tel Aviv University Sackler Faculty of Medicine in Tel Aviv, Israel. He completed a subsequent internship and residency in internal medicine at the New York Infirmary Beekman Downtown Hospital under the auspices of New York University, in New York, New York. His fellowship in diabetes and endocrinology was conducted at the University of Southern California Medical School in Los Angeles, California.

 

Philip Levy, M.D., MACE

Clinical Professor of Medicine, University of Arizona College of Medicine
Chairman, Section of Endocrinology & Metabolism, Banner Good Samaritan Regional Medical Center

Philip Levy, M.D., MACE, is a clinical professor of medicine at the University of Arizona College of Medicine, and is chairman of the Section of Endocrinology and Metabolism at Banner Good Samaritan Regional Medical Center in Phoenix, Arizona, as well as past chief of staff and past chairman of medicine. He has practiced clinical endocrinology at Phoenix Endocrinology Clinic, LTD in Phoenix for more than 40 years. Dr. Levy graduated from the University of Pittsburgh School of Medicine in Pittsburgh, PA. He completed his internship, internal medicine residency, and fellowship in metabolism and endocrinology at Michael Reese Hospital and Medical Center in Chicago, Illinois. Dr. Levy was a research fellow in endocrinology at Guy’s Hospital Medical Center in London, England.

Dr. Levy served on the American Association of Clinical Endocrinologists (AACE) Board of Directors for six years, is past president of the American College of Endocrinology and currently serves as editor-in-chief of The First Messenger. He is past president and founding member of the board of directors of the Arizona Diabetes Association (ADA). Dr. Levy is an active member of AACE, American Medical Association and ADA in numerous capacities. He is a past member of The American Diabetes Association Board of Directors. He is also an Arizona Division of Motor Vehicles Medical Advisory Board Member, member of the Arizona Blue Shield, The Endocrine Society, American College of Physicians, Society of Nuclear Medicine, Arizona Medical Association, Clinical Endocrinology Editorial Board, and Endocrine Today Editorial Board. Dr. Levy is former Diabetes Forecast editor in chief and Clinical Diabetes editorial board member. He is a past editorial board member of Endocrine Practice. He is also a life member of the National Registry of Who’s Who.

Dr. Levy was presented the AACE Yank D. Coble, Jr., M.D., Distinguished Service Award in 2000 and the Master of the American College of Endocrinology Award in 2008.